- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 94.3M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $610.82M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $16.2M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $19.57M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $77.04M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $472.55M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $289.47M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.21B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $317.87M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $534.08M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $343.13M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.69B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $549.21M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $89.09M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $71.36M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 49.27M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $4.02M |
| Capex | Q1 2025 · Mar 31, 2024 | $1.34M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $8.61M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $216.93M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $223.06M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.10 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.10 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $15.22M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $9.19M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$5.04M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$6.6M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $41.6M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $175.37M |
| Revenue | Q1 2025 · Mar 31, 2024 | $216.96M |